Westat
The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (launching in October 2026) ) and up to 3 months during the pilot inconducted April - September 2026. This study aims to confirm a lack of negative health effects Source Plasma donors may experience as a result of frequent plasmapheresis. The study will use data obtained through self-report surveys for the duration of the study along with periodic whole blood sample collections to test for CRP, ferritin, and IgG.
The study employs a two-phase prospective design: (1) data collected before and 48-72 hours after an initial plasma and (2) data collected for up to 24 months through surveys and specimen collections. Data will be collected through electronic surveys, real-time illness reports, biomarker analyses, and extracts of Blood Establishment Computer Software (BECS) records including donor screening and operational collection processing variables, if available. Study staff (Study Coordinators employed by the plasma collection companies) will engage with participants directly and Westat systems will be…
Inclusion Criteria: * Aged 18-74; * Meet health and medical history requirements for being a plasma donor per eCFR::21 CFR 630.10 Subpart B -- General donor eligibility requirements; * Willing to provide phone number and mailing address; has access to internet-enabled smartphone device; * Plans to remain within local area during study duration; has not donated whole blood within past 12 months; * Does not have permanent deferral; * Has not donated plasma more than once at a non-participating company plasma center; * Another member of their household is not enrolled. * Is not employed by the p…
Both pilot and main cohort will undergo plasmapheresis (plasma donation) as part of their initial visit for the study. Some participants will donate plasma throughout the duration of either cohort (3 months in pilot or up to 2 years in the main study.